Free Trial
Stacy Ku

Stacy Ku Analyst Performance

Biotechnology Equity Research at TD Cowen

Stacy Ku is a stock analyst at TD Cowen in the healthcare sector, covering 9 publicly traded companies. Over the past year, Stacy Ku has issued 4 stock ratings, including strong buy and buy recommendations. While full access to Stacy Ku's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Stacy Ku's coverage history, rating activity, and performance tendencies - helping individual investors make more informed trading decisions.

Analyst Rankings, Coverage, and Performance Statistics

Average Return
00.00% 12-Month ROI
Success Rate
00.00% Profitable Ratings
Total Ratings
11 Last 2 Years
Buy Recommendations
100.00% 11 Buy Ratings
Companies Covered
9 Unique Companies

Ratings Distribution

RatingPercentageCount
Strong Buy9.1%1 ratings
Buy90.9%10 ratings
Hold0.0%0 ratings
Sell0.0%0 ratings

Out of 11 total stock ratings issued by Stacy Ku at TD Cowen, the majority (90.9%) have been Buy recommendations, followed by 9.1% Strong Buy.

Exchange Coverage

ExchangePercentageCount
NASDAQ
100.0% of companies on NASDAQ
9 companies

Stacy Ku, an analyst at TD Cowen, currently covers 9 companies listed on , with the majority traded on NASDAQ.

Coverage Focus

Sector IconSectorPercentage
Healthcare
9 companies
100.0%

Stacy Ku of TD Cowen specializes in stock coverage within the Healthcare sector.

Coverage Industries

IndustryPercentage
PHARMACEUTICALS
5 companies
55.6%
BIOTECHNOLOGY
4 companies
44.4%

Stacy Ku's Ratings History at TD Cowen

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription
12-Month ROIUpgrade to All Access to use the All ROI Filter
0 Results
CompanyReport DateActionReport Date Price12-Month
Price Target
Rating12-Month
Price & ROI
Details
Aurinia Pharmaceuticals Inc stock logo
AUPH
Aurinia Pharmaceuticals
10/21/2026Boost Price Target$16.74$18.00Buy
Tonix Pharmaceuticals Holding Corp. stock logo
TNXP
Tonix Pharmaceuticals
5/5/2026Upgrade$13.50Strong-Buy
Tonix Pharmaceuticals Holding Corp. stock logo
TNXP
Tonix Pharmaceuticals
5/4/2026Initiated Coverage$13.60$22.00Buy
Grace Therapeutics, Inc. stock logo
GRCE
Grace Therapeutics
4/24/2026Lower Price Target$2.35$8.00Buy
Supernus Pharmaceuticals, Inc. stock logo
SUPN
Supernus Pharmaceuticals
10/23/2025Boost Price Target$51.74$60.00Buy
BioCryst Pharmaceuticals, Inc. stock logo
BCRX
BioCryst Pharmaceuticals
10/15/2025Initiated Coverage$6.42$30.00Buy
Grace Therapeutics, Inc. stock logo
GRCE
Grace Therapeutics
5/2/2025Initiated Coverage$2.71$12.00Buy
LENZ Therapeutics, Inc. stock logo
LENZ
LENZ Therapeutics
3/18/2025Initiated Coverage$23.59$60.00Buy
Centessa Pharmaceuticals PLC Sponsored ADR stock logo
CNTA
Centessa Pharmaceuticals
1/7/2025Initiated Coverage$16.74Buy
KalVista Pharmaceuticals, Inc. stock logo
KALV
KalVista Pharmaceuticals
1/7/2025Initiated Coverage$8.68$30.00Buy